Pulmonary Hypertension in Acute and Chronic High Altitude Maladaptation Disorders

肺动脉高压 医学 高原肺水肿 缺氧性肺血管收缩 缺氧(环境) 心脏病学 适应不良 高海拔对人类的影响 内科学 硝苯地平 肺动脉 高原病 肺水肿 重症监护医学 有机化学 化学 氧气 精神科 解剖
作者
Akylbek Sydykov,Argen Mamazhakypov,Abdirashit Maripov,Djuro Kosanovic,Norbert Weißmann,Hossein Ardeschir Ghofrani,Akpay Sarybaev,Ralph T. Schermuly
出处
期刊:International Journal of Environmental Research and Public Health [Multidisciplinary Digital Publishing Institute]
卷期号:18 (4): 1692-1692 被引量:137
标识
DOI:10.3390/ijerph18041692
摘要

Alveolar hypoxia is the most prominent feature of high altitude environment with well-known consequences for the cardio-pulmonary system, including development of pulmonary hypertension. Pulmonary hypertension due to an exaggerated hypoxic pulmonary vasoconstriction contributes to high altitude pulmonary edema (HAPE), a life-threatening disorder, occurring at high altitudes in non-acclimatized healthy individuals. Despite a strong physiologic rationale for using vasodilators for prevention and treatment of HAPE, no systematic studies of their efficacy have been conducted to date. Calcium-channel blockers are currently recommended for drug prophylaxis in high-risk individuals with a clear history of recurrent HAPE based on the extensive clinical experience with nifedipine in HAPE prevention in susceptible individuals. Chronic exposure to hypoxia induces pulmonary vascular remodeling and development of pulmonary hypertension, which places an increased pressure load on the right ventricle leading to right heart failure. Further, pulmonary hypertension along with excessive erythrocytosis may complicate chronic mountain sickness, another high altitude maladaptation disorder. Importantly, other causes than hypoxia may potentially underlie and/or contribute to pulmonary hypertension at high altitude, such as chronic heart and lung diseases, thrombotic or embolic diseases. Extensive clinical experience with drugs in patients with pulmonary arterial hypertension suggests their potential for treatment of high altitude pulmonary hypertension. Small studies have demonstrated their efficacy in reducing pulmonary artery pressure in high altitude residents. However, no drugs have been approved to date for the therapy of chronic high altitude pulmonary hypertension. This work provides a literature review on the role of pulmonary hypertension in the pathogenesis of acute and chronic high altitude maladaptation disorders and summarizes current knowledge regarding potential treatment options.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
丘比特应助体贴电话采纳,获得10
刚刚
mira发布了新的文献求助10
1秒前
1秒前
EchoH完成签到 ,获得积分10
1秒前
wakaka发布了新的文献求助10
1秒前
拾陆完成签到,获得积分10
1秒前
王木木发布了新的文献求助10
2秒前
WXY发布了新的文献求助10
2秒前
传奇3应助yeemelo采纳,获得10
3秒前
3秒前
JamesPei应助小茵采纳,获得10
3秒前
一笑就成傻白甜给一笑就成傻白甜的求助进行了留言
3秒前
蒲公英完成签到,获得积分20
3秒前
闫栋发布了新的文献求助10
4秒前
蜚英腾茂完成签到,获得积分10
4秒前
ding应助wakaka采纳,获得10
5秒前
6秒前
dyfsj发布了新的文献求助10
6秒前
打打应助keroro采纳,获得10
9秒前
9秒前
Demon发布了新的文献求助10
9秒前
Joyce发布了新的文献求助10
9秒前
10秒前
朝圣者完成签到,获得积分10
12秒前
暴躁的鸽子完成签到,获得积分10
12秒前
12秒前
Avalonx应助野人采纳,获得15
14秒前
乐乐应助撒GE采纳,获得10
14秒前
14秒前
15秒前
15秒前
玛斯特尔完成签到,获得积分10
15秒前
体贴电话发布了新的文献求助10
15秒前
dyfsj完成签到,获得积分10
16秒前
17秒前
molihuakai应助小烟囱采纳,获得10
17秒前
科目三应助积极的猎豹采纳,获得10
17秒前
andou完成签到,获得积分10
19秒前
Lucas应助蒲公英采纳,获得10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Developing Genetic Editing Tools for Lysobacter 2000
Моделирование процессов самоорганизации в кристаллообразующих системах 1000
History of U.S. Space Surveillance and Satellite Cataloging 1000
Adhesion Science: Principles & Practice 800
Signals, Systems, and Signal Processing 610
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6524637
求助须知:如何正确求助?哪些是违规求助? 8317936
关于积分的说明 17800586
捐赠科研通 5626477
什么是DOI,文献DOI怎么找? 2928736
邀请新用户注册赠送积分活动 1905450
关于科研通互助平台的介绍 1765380